Cytori Cell Research Institute (TSE:3750) YoY EBITDA Growth : 46.37% (As of Dec. 2023)

View and export this data going back to 2004. Start your Free Trial

What is Cytori Cell Research Institute YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Cytori Cell Research Institute's YoY EBITDA Growth for the quarter that ended in Dec. 2023 was 46.37%.

Cytori Cell Research Institute's EBITDA per Share for the three months ended in Dec. 2023 was 円-8.30.

Cytori Cell Research Institute YoY EBITDA Growth Historical Data

The historical data trend for Cytori Cell Research Institute's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytori Cell Research Institute YoY EBITDA Growth Chart

Cytori Cell Research Institute Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

YoY EBITDA Growth

Get a 7-Day Free Trial

46.91

-19.19

-139.02

223.49

-299.92

Cytori Cell Research Institute Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
YoY EBITDA Growth	Get a 7-Day Free Trial															-219.72	-414.94	52.39	-0.25	46.37

Cytori Cell Research Institute YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Cytori Cell Research Institute's YoY EBITDA Growth for the fiscal year that ended in Mar. 2023 is calculated as:

	YoY EBITDA Growth (A: Mar. 2023 )
=	(EBITDA per Share (A: Mar. 2023 )	-	EBITDA per Share (A: Mar. 2022 ))	/	\| EBITDA per Share (A: Mar. 2022 ) \|
=	(-78.995	-	39.513)	/	\| 39.513 \|
=	-299.92 %

Cytori Cell Research Institute's YoY EBITDA Growth for the quarter that ended in Dec. 2023 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2023 )
=	(EBITDA per Share (Q: Dec. 2023 )	-	EBITDA per Share (Q: Dec. 2022 ))	/	\| EBITDA per Share (Q: Dec. 2022 )) \|
=	(-8.301	-	-15.479)	/	\| -15.479 \|
=	46.37 %

Cytori Cell Research Institute YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Cytori Cell Research Institute's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytori Cell Research Institute (TSE:3750) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytori Cell Research Institute Inc (TSE:3750) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

1-1-1 Otemachi, Otemachi Park Building, Chiyoda-ku, Tokyo, JPN, 100-0004

Website

https://www.cytori.co.jp

Cytori Cell Research Institute Inc developing a new clinical approach to cell therapy to provide better medical care to patients by providing medical care that responds to unmet medical needs based on innovative regenerative medicine. Its product pipeline includes Habeo; ECCO-50 and others.

Cytori Cell Research Institute (TSE:3750) Headlines

No Headlines